$10. 6 billion deal: GSK to buy US cancer specialist NuvalentGSK in talks to buy cancer biotech Nuvalent for more than $9 billionStocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
FOREX-Dollar steadies following US strikes on Iran and ahead of inflation data
Where Zepto stands in q-comm; H-1B relief kicks in
Bitcoin’s worst week since FTX crash signals more pain ahead
Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chains
Oil rises nearly 1% as US launches new strikes against Iran, supply tightens
SpaceX aims to launch orbital AI computing tests by end of next year
GIFT Nifty rises 100 points, hints at positive start; key trading cues for today
Regional retail companies chase IPO gold to fund dreams
Gold drops as oil climbs on renewed US-Iran hostilities
Elon Musk's xAI, SpaceX hit with class action over data center 'nuisance'
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service